DEPDC1B and neoplasm: The results revealed that the AMPK activator could counteract the enhanced migratory and invasive properties induced by XTP8 overexpression (Supplementary Fig. 3A–D).To validate whether XTP8 affects tumor EMT through the AKT/AMPK/MTOR signaling pathway, we also examined the expression of EMT-related proteins.